Skip to main content

AMERIPRISE FINANCIAL INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,362,361
-$23,195,189 QoQ
Shares Held
191,279
-63.8% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 93.06980902242275.ToString("F0")% None 6.930190977577257.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. HALO ranks #39 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,362,361 191,279
2025-12-31 $35,557,550 528,344
2025-09-30 $22,897,333 312,208
2025-06-30 $8,587,304 165,077
2025-03-31 $43,470,689 681,252
2024-12-31 $31,123,448 650,982
2024-09-30 $19,968,173 348,850
2024-06-30 $19,418,543 370,866
2024-03-31 $15,962,140 392,383
2023-12-31 $17,182,961 464,907
2023-09-30 $17,080,861 447,143
2023-06-30 $16,890,028 468,257
2023-03-31 $19,815,606 518,869
2022-12-31 $29,947,720 526,322
2022-09-30 $24,674,145 624,030
2022-06-30 $27,673,800 628,950
2022-03-31 $26,426,002 662,638
2021-12-31 $25,377,615 631,127
2021-09-30 $23,865,531 586,665
2021-06-30 $25,974,790 572,006
2021-03-31 $24,772,697 594,212
2020-12-31 $28,579,096 669,143
2020-09-30 $11,480,785 436,864
2020-06-30 $11,758,597 438,590
2020-03-31 $7,353,537 408,757